Growing community of inventors

Dijon, France

Claire Bernhard

Average Co-Inventor Count = 4.61

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Claire BernhardMichael Chorev (15 patents)Claire BernhardFranck Denat (3 patents)Claire BernhardFrederic Boschetti (2 patents)Claire BernhardYoann Rousselin (2 patents)Claire BernhardPauline Desogere (2 patents)Claire BernhardFrédéric Boschetti (1 patent)Claire BernhardVictor Goncalves (1 patent)Claire BernhardColine Canovas (1 patent)Claire BernhardDébora D'Addona (0 patent)Claire BernhardAnna Maria Rovero (0 patent)Claire BernhardDebora M D'Addona (0 patent)Claire BernhardClaire Bernhard (3 patents)Michael ChorevMichael Chorev (15 patents)Franck DenatFranck Denat (11 patents)Frederic BoschettiFrederic Boschetti (4 patents)Yoann RousselinYoann Rousselin (2 patents)Pauline DesogerePauline Desogere (2 patents)Frédéric BoschettiFrédéric Boschetti (1 patent)Victor GoncalvesVictor Goncalves (1 patent)Coline CanovasColine Canovas (1 patent)Débora D'AddonaDébora D'Addona (0 patent)Anna Maria RoveroAnna Maria Rovero (0 patent)Debora M D'AddonaDebora M D'Addona (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre National De La Recherche Scientifique (3 from 5,089 patents)

2. Université De Bourgogne (3 from 37 patents)

3. Université De Cergy Pontoise (8 patents)

4. Université De Bourgogne Dijon (0 patent)


3 patents:

1. 11242359 - Biocompatible modular tetrazine platform

2. 9988388 - Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C- functionalized derivatives thereof

3. 9981967 - Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C-functionalized derivatives thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/30/2025
Loading…